Recombinant human TSH versus thyroid hormone withdrawal in adjuvant therapy with radioactive iodine of patients with papillary thyroid carcinoma and clinically apparent lymph node metastases not limited to the central compartment (cN1b)

OBJECTIVE: To compare the short- and long-term outcomes of adjuvant therapy with radioactive iodine (RAI) preceded by the administration of recombinant human TSH (rhTSH) versus thyroid hormone withdrawal (THW) in patients with papillary thyroid carcinoma and clinically apparent lymph node metastases...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosario, Pedro Weslley, Mourão, Gabriela Franco, Calsolari, Maria Regina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Endocrinologia e Metabologia 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118864/
https://www.ncbi.nlm.nih.gov/pubmed/28226001
http://dx.doi.org/10.1590/2359-3997000000247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118864/
https://www.ncbi.nlm.nih.gov/pubmed/28226001
http://dx.doi.org/10.1590/2359-3997000000247

Ejemplares similares